Can amantadine be administered once daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Amantadine Be Given Once Daily?

Yes, amantadine can be administered once daily, but this is only appropriate for specific populations and formulations—standard immediate-release amantadine requires twice-daily dosing for most patients, while extended-release formulations are specifically designed for once-daily administration.

Standard Immediate-Release Formulation Dosing

Adults Under 65 Years

  • Standard dosing is 100 mg twice daily (200 mg total daily dose) for both influenza prophylaxis/treatment and Parkinson's disease 1, 2
  • The FDA label explicitly states that while 200 mg can be given as a single daily dose, if CNS side effects develop with once-daily dosing, a split dosage schedule (twice daily) may reduce such complaints 2
  • Once-daily dosing at 200 mg has not been demonstrated to be as effective as the standard twice-daily regimen for all indications 2

Adults 65 Years and Older

  • The total daily dose should be reduced to 100 mg per day due to age-related decline in renal function 1, 3, 4, 2
  • This 100 mg can be given as a single daily dose in elderly patients 2
  • The lower dose minimizes CNS side effects while maintaining efficacy 3

Pediatric Patients

  • Children require twice-daily dosing 1, 2
  • Ages 1-9 years: 5 mg/kg/day divided into two doses (maximum 150 mg/day) 1, 2
  • Ages 10-12 years: 100 mg twice daily 1, 2

Extended-Release Formulations

ADS-5102 (Bedtime Dosing)

  • ADS-5102 is specifically designed for once-daily administration at bedtime 5, 6
  • This formulation provides high amantadine concentrations upon waking and throughout the day, with lower concentrations in the evening 5
  • Peak concentration occurs 12-16 hours post-dose, resulting in mid-day peak levels when dyskinesia symptoms are most problematic 5
  • Effective doses range from 260-340 mg once daily at bedtime for levodopa-induced dyskinesia 6

OS320 (Morning Dosing)

  • OS320 extended-release tablets allow once-daily morning administration 7
  • Peak amantadine concentration occurs approximately 7.5 hours post-dose 7
  • At steady state, once-daily extended-release dosing is bioequivalent to twice-daily immediate-release dosing at the same total daily dose 7

Renal Impairment Adjustments

Dose reduction is mandatory for renal dysfunction, which may result in effective once-daily dosing:

  • Creatinine clearance 30-50 mL/min/1.73m²: 200 mg on day 1, then 100 mg once daily 2
  • Creatinine clearance 15-29 mL/min/1.73m²: 200 mg on day 1, then 100 mg every other day 2
  • Creatinine clearance <15 mL/min/1.73m²: 200 mg every 7 days 2
  • Hemodialysis patients: 200 mg every 7 days 2

Clinical Considerations

When Once-Daily Dosing May Be Appropriate

  • Elderly patients (≥65 years) receiving the reduced 100 mg daily dose 1, 2
  • Patients with renal impairment requiring dose reduction 2
  • Patients using extended-release formulations specifically designed for once-daily administration 5, 7, 6
  • Patients experiencing intolerance to 200 mg daily who require dose reduction to 100 mg 2

Important Caveats

  • The 100 mg once-daily dose has not been studied for treatment of acute influenza illness and may not be as effective as 200 mg daily for prophylaxis 2
  • If sleep disturbances occur with twice-daily dosing, avoid taking the second dose too close to bedtime rather than switching to once-daily dosing 3
  • Standard immediate-release formulations given once daily at 200 mg may cause more CNS side effects than split dosing 2
  • Extended-release and immediate-release formulations are not bioequivalent and cannot be substituted on a mg-per-mg basis 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.